Use of expression data and the CGEMS genome-wide breast cancer association study to identify genes that may modify risk in BRCA1/2 mutation carriers

Breast Cancer Research and Treatment

Volumn 112, Issue 2, 2008, Pages 229-236

  Walker, Logan C ^a   Waddell, Nic ^a   Ten Haaf, Anette ^a   Grimmond, Sean ^b   Spurdle, Amanda B ^a  

^a ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

BRCA1; BRCA2; BRCAX; Breast cancer; Cancer Genetic Markers of Susceptibilty (CGEMS); Cell cycle; Irradiation; Microarray; Modifier genes

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

ARTICLE; BREAST CANCER; CANCER GENETICS; CANCER RISK; CANCER SUSCEPTIBILITY; CELL CYCLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FAMILY HISTORY; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; GENE MUTATION; GENE TARGETING; GENETIC MARKER; GENETIC RISK; HETEROZYGOTE; HUMAN; HUMAN CELL; IRRADIATION; LYMPHOBLASTOID CELL; MICROARRAY ANALYSIS; OVARY CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

BREAST NEOPLASMS; CELL LINE, TUMOR; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, BRCA1; GENES, BRCA2; GENETIC PREDISPOSITION TO DISEASE; GENOME, HUMAN; HETEROZYGOTE; HUMANS; MUTATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 53949111816     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10549-007-9848-5     Document Type: Article

References (41)

1. RA Oldenburg H Meijers-Heijboer CJ Cornelisse 2007 Genetic susceptibility for breast cancer: how many more genes to be found? Crit Rev Oncol Hematol 63 2 125 149
2. A Antoniou PD Pharoah S Narod 2003 Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies Am J Hum Genet 72 5 1117 1130
3. S Simchoni E Friedman B Kaufman 2006 Familial clustering of site-specific cancer risks associated with BRCA1 and BRCA2 mutations in the Ashkenazi Jewish population Proc Natl Acad Sci USA 103 10 3770 3774
4. A Smith A Moran MC Boyd 2007 Phenocopies in BRCA1 and BRCA2 families: evidence for modifier genes and implications for screening J Med Genet 44 1 10 15
5. AC Antoniou OM Sinilnikova J Simard 2007 RAD51 135G>C modifies breast cancer risk among BRCA2 mutation carriers: results from a combined analysis of 19 studies Am J Hum Genet 81 6 1186 1200
6. A Osorio B Martinez-Delgado M Pollan 2006 A haplotype containing the p53 polymorphisms Ins16bp and Arg72Pro modifies cancer risk in BRCA2 mutation carriers Hum Mutat 27 3 242 248
7. TR Rebbeck PW Kantoff K Krithivas 1999 Modification of BRCA1-associated breast cancer risk by the polymorphic androgen-receptor CAG repeat Am J Hum Genet 64 5 1371 1377
8. TR Rebbeck Y Wang PW Kantoff 2001 Modification of BRCA1- and BRCA2-associated breast cancer risk by AIB1 genotype and reproductive history Cancer Res 61 14 5420 5424
9. AB Spurdle AC Antoniou DL Duffy 2005 The androgen receptor CAG repeat polymorphism and modification of breast cancer risk in BRCA1 and BRCA2 mutation carriers Breast Cancer Res 7 2 R176 R183
10. AB Spurdle AC Antoniou L Kelemen 2006 The AIB1 polyglutamine repeat does not modify breast cancer risk in BRCA1 and BRCA2 mutation carriers Cancer Epidemiol Biomarkers Prev 15 1 76 79
11. P Karran 2000 DNA double strand break repair in mammalian cells Curr Opin Genet Dev 10 2 144 150
12. MK Shivji OR Davies JM Savill 2006 A region of human BRCA2 containing multiple BRC repeats promotes RAD51-mediated strand exchange Nucleic Acids Res 34 14 4000 4011
13. A Broeks LM Braaf A Huseinovic 2007 Identification of women with an increased risk of developing radiation-induced breast cancer: a case only study Breast Cancer Res 9 2 R26
14. PB Mullan JE Quinn DP Harkin 2006 The role of BRCA1 in transcriptional regulation and cell cycle control Oncogene 25 43 5854 5863
15. LY Marmorstein AV Kinev GK Chan 2001 A human BRCA2 complex containing a structural DNA binding component influences cell cycle progression Cell 104 2 247 257
16. GJ Mann H Thorne RL Balleine 2006 Analysis of cancer risk and BRCA1 and BRCA2 mutation prevalence in the kConFab familial breast cancer resource Breast Cancer Res 8 1 R12
17. A Marsh S Healey A Lewis 2007 Mutation analysis of five candidate genes in familial breast cancer Breast Cancer Res Treat 105 3 377 389
18. G Chenevix-Trench S Healey S Lakhani 2006 Genetic and histopathologic evaluation of BRCA1 and BRCA2 DNA sequence variants of unknown clinical significance Cancer Res 66 4 2019 2027
19. KY Jen VG Cheung 2003 Transcriptional response of lymphoblastoid cells to ionizing radiation Genome Res 13 9 2092 2100
20. MA Eberle PC Ng K Kuhn 2007 Power to detect risk alleles using genome-wide tag SNP panels PLoS Genet 3 10 1827 1837
21. DF Easton KA Pooley AM Dunning 2007 Genome-wide association study identifies novel breast cancer susceptibility loci Nature 447 7148 1087 1093
22. KJ Bussey D Kane M Sunshine 2003 MatchMiner: a tool for batch navigation among gene and gene product identifiers Genome Biol 4 4 R27
23. P Smith L McGuffog DF Easton 2006 A genome wide linkage search for breast cancer susceptibility genes Genes Chromosomes Cancer 45 7 646 655
24. A Cox AM Dunning M Garcia-Closas 2007 A common coding variant in CASP8 is associated with breast cancer risk Nat Genet 39 3 352 358
25. N Rahman S Seal D Thompson 2007 PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene Nat Genet 39 2 165 167
26. A Renwick D Thompson S Seal 2006 ATM mutations that cause ataxia-telangiectasia are breast cancer susceptibility alleles Nat Genet 38 8 873 875
27. S Seal D Thompson A Renwick 2006 Truncating mutations in the Fanconi anemia J gene BRIP1 are low-penetrance breast cancer susceptibility alleles Nat Genet 38 11 1239 1241
28. J Steffen D Nowakowska A Niwinska 2006 Germline mutations 657del5 of the NBS1 gene contribute significantly to the incidence of breast cancer in Central Poland Int J Cancer 119 2 472 475
29. A Dubrovska T Kanamoto M Lomnytska 2005 TGFbeta1/Smad3 counteracts BRCA1-dependent repair of DNA damage Oncogene 24 14 2289 2297
30. YF Hu R Li 2002 JunB potentiates function of BRCA1 activation domain 1 (AD1) through a coiled-coil-mediated interaction Genes Dev 16 12 1509 1517
31. O Preobrazhenska M Yakymovych T Kanamoto 2002 BRCA2 and Smad3 synergize in regulation of gene transcription Oncogene 21 36 5660 5664
32. M Krendel FT Zenke GM Bokoch 2002 Nucleotide exchange factor GEF-H1 mediates cross-talk between microtubules and the actin cytoskeleton Nat Cell Biol 4 4 294 301
33. MA Wozniak R Desai PA Solski 2003 ROCK-generated contractility regulates breast epithelial cell differentiation in response to the physical properties of a three-dimensional collagen matrix J Cell Biol 163 3 583 595
34. JL Gooch AV Lee D Yee 1998 Interleukin 4 inhibits growth and induces apoptosis in human breast cancer cells Cancer Res 58 18 4199 4205
35. SP Balasubramanian IA Azmy SE Higham 2006 Interleukin gene polymorphisms and breast cancer: a case control study and systematic literature review BMC Cancer 6 188
36. TIH Consortium 2003 The international HapMap project Nature 426 6968 789 796
37. C Papageorgio R Brachmann J Zeng 2007 MAGED2: a novel p53-dissociator Int J Oncol 31 5 1205 1211
38. M Schuyer EM Berns 1999 Is TP53 dysfunction required for BRCA1-associated carcinogenesis? Mol Cell Endocrinol 155 1-2 143 152
39. PJ Welch JY Wang 1993 A C-terminal protein-binding domain in the retinoblastoma protein regulates nuclear c-Abl tyrosine kinase in the cell cycle Cell 75 4 779 790
40. S Gery N Komatsu L Baldjyan 2006 The circadian gene per1 plays an important role in cell growth and DNA damage control in human cancer cells Mol Cell 22 3 375 382
41. SL Winter L Bosnoyan-Collins D Pinnaduwage 2007 Expression of the circadian clock genes Per1 and Per2 in sporadic and familial breast tumors Neoplasia 9 10 797 800